Name | Description | SBIR/STTR Award Recipient | Government Agency | Government Branch | Award Type | Contract Number (US Government) | Award Phase | Award Amount (USD) | Date Awarded | Official Website | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
A STTR Phase I contract was awarded to Sensei Biotherapeutics in August, 2009 for $100,000.0 USD from the U.S. Department of Defense. | STTR | W81XWH-09-C-0151 | Phase I | 100,000 | August 10, 2009 | |||||||
A SBIR Phase I contract was awarded to Sensei Biotherapeutics for $100,000.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43AG024775-01 | Phase I | 100,000 | ||||||||
A SBIR Phase I contract was awarded to Sensei Biotherapeutics for $150,122.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43NS048694-01 | Phase I | 150,122 | ||||||||
A SBIR Phase I contract was awarded to Sensei Biotherapeutics for $125,591.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43AI051047-01 | Phase I | 125,591 | ||||||||
A SBIR Phase II contract was awarded to Sensei Biotherapeutics for $2,155,268.0 USD from the U.S. Department of Health & Human Services. | SBIR | 2R44AI051047-02 | Phase II | 2,155,268 | ||||||||
A SBIR Phase I contract was awarded to Sensei Biotherapeutics for $143,045.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43AI052668-01 | Phase I | 143,045 | ||||||||
A SBIR Phase II contract was awarded to Sensei Biotherapeutics for $749,684.0 USD from the U.S. Department of Health & Human Services. | SBIR | 2R44AI052668-02 | Phase II | 749,684 | ||||||||
A SBIR Phase I contract was awarded to Sensei Biotherapeutics for $593,356.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43AI056915-01 | Phase I | 593,356 | ||||||||
A SBIR Phase II contract was awarded to Sensei Biotherapeutics for $880,944.0 USD from the U.S. Department of Health & Human Services. | SBIR | 9R44HL085043-02 | Phase II | 880,944 | ||||||||
A SBIR Phase I contract was awarded to Sensei Biotherapeutics for $97,491.0 USD from the U.S. Department of Health & Human Services. | SBIR | Phase I | 97,491 |